Scholarly Index
Yinghong Wang
The University of Texas MD Anderson Cancer Center; 15,642 total citations; 543 total publications; best world rank #54
The University of Texas MD Anderson Cancer Center
15,642Total citations
543Total publications
50H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 643 | US 322 | 98.58 |
| Colorectal Cancer Treatments and Studies | Lifetime | 718 | US 297 | 97.91 |
| Microscopic Colitis | Lifetime | 608 | US 175 | 97.03 |
| Neutropenia and Cancer Infections | Lifetime | 384 | US 182 | 96.80 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 737 | US 315 | 95.19 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 207 | US 83 | 99.21 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 181 | US 65 | 97.64 |
| Microscopic Colitis | 2021-2025 | 117 | US 36 | 98.08 |
| Neutropenia and Cancer Infections | 2021-2025 | 54 | US 21 | 95.40 |
| Inflammatory Bowel Disease | 2021-2025 | 544 | US 110 | 94.16 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 401 | US 113 | 87.79 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 978 | US 102 | 81.19 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 781 | US 53 | 75.35 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 569 | US 89 | 53.49 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 939 | US 309 | 45.35 |